Advanced yield and purity
Boost yield and purity with technologies that intensify your upstream production and optimize your downstream processing.
Boost productivity, recovery, and throughput with our advanced, scalable biomanufacturing systems. Designed to meet your specific needs, our solutions support critical stages of your biotherapeutics pipeline, supporting consistent quality from discovery to commercial manufacture. Explore our tailored portfolio of differentiated products to enhance your operations and maximize productivity.
Explore SolarisLab, SolarisIndustrial, and Solaris Filtration systems, offering capacities from 0.2 to 30,000 L.
Achieve up to a 10x increase in cell culture productivity with scale-X™ bioreactors & the NevoLine™ Upstream Platform.
IsoTag™ purifies biologics without chromatography at 30x faster concentration with 96% product retention.
Purexa™ chromatography membranes offer up to 10x higher productivity than traditional resin chromatography.
Cell and Gene Therapy
Vaccines
RNA & DNA
Extracellular Vesicles
Stem Cells
Peptides & Proteins
Cultivated Meat
Cosmetics
Boost yield and purity with technologies that intensify your upstream production and optimize your downstream processing.
Experience fast processing times with our flexible streamlined systems that shorten cycles, speed up turnaround, and boost overall productivity.
Manage your manufacturing costs and your cost-per-dose by moving to our high-throughput production systems that improve yield and purity.
Our bioprocessing solutions are designed to meet the diverse needs of our customers across various stages of the biomanufacturing process.
Our products enable quick adjustments and dynamic approaches - putting science first. Each product in the Donalson Life Science portfolio was developed with, for, and by researchers.
Our bioprocessing technologies are engineered to scale seamlessly, supporting the transition from small-scale experiments to larger production runs that optimize resource use.
Our solutions offer robust, high-quality performance that meet stringent regulatory requirements, allowing our clients to deliver effective biotherapeutics to the market, fast.